The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A randomized, placebo-controlled, double blind, multicenter phase II adjuvant trial of the efficacy, immunogenicity, and safety of GI-4000 plus gem versus gem alone in patients with resected pancreas cancer with activating RAS mutations/survival and immunology analysis of the R1 subgroup.
Peter Muscarella
Research Funding - GlobeImmune
Lalan S. Wilfong
No relevant relationships to disclose
Sharona B. Ross
Consultant or Advisory Role - Covidien; Olympus Medical Systems
Honoraria - Covidien; Olympus Medical Systems
Research Funding - Covidien
Donald A. Richards
No relevant relationships to disclose
Julian Raynov
No relevant relationships to disclose
William E. Fisher
Research Funding - GlobeImmune
Patrick J. Flynn
No relevant relationships to disclose
Samuel H. Whiting
Research Funding - GlobeImmune
Alexander Rosemurgy
Consultant or Advisory Role - Covidien; Olympus Medical Systems
Honoraria - Covidien; Olympus Medical Systems
Research Funding - Covidien; Olympus Medical Systems
Frank E Harrell
Research Funding - GlobeImmune
Nathaniel D. Mercaldo
No relevant relationships to disclose
Scott Kosten
Consultant or Advisory Role - GlobeImmune
John Quiring
Consultant or Advisory Role - GlobeImmune
Sue Speyer
Employment or Leadership Position - GlobeImmune
Joni Richman
Employment or Leadership Position - GlobeImmune
John Ferraro
Employment or Leadership Position - GlobeImmune
Stock Ownership - GlobeImmune
Claire Coeshott
Employment or Leadership Position - GlobeImmune
Allen Cohn
Employment or Leadership Position - GlobeImmune
Timothy C. Rodell
Employment or Leadership Position - GlobeImmune
Stock Ownership - GlobeImmune
Research Funding - GlobeImmune
Other Remuneration - GlobeImmune
David Apelian
Employment or Leadership Position - GlobeImmune
Stock Ownership - GlobeImmune